Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...
U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government testing found they contain slightly elevated levels ...
17h
Zacks Investment Research on MSNPharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline UpdateNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...
After new U.S. Food and Drug Administration testing of acne products containing benzoyl peroxide, the agency determined that ...
Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.
The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.
Popular skincare brands are issuing a recall on items sold at retailers including Walgreens and Target over a cancer-linked ingredient.
Several major skin care brands like L’Oréal Paris and Proactiv issued a recall of their products due to elevated levels of ...
The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain slightly elevated levels of a chemical linked to cancer ...
The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results